Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

Name: Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
License: Public Domain

Children's Oncology Group

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

ganglioneuroblastoma, nodular, neuroblastoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 353290
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.